ChronicleBio Is Coming for Chronic Disease: Pioneering Immunologist Joins Elite Scientific Team to Translate Biological Signal into Targeted Therapeutics

The Emerging Techbio Company Appoints Dr. John Mumm as CSO Alongside Head of Platform Dr. Yambazi Banda to Decode the Molecular Underpinnings of Neuroimmune Conditions SAN FRANCISCO, June 11, 2026 /PRNewswire/ -- ChronicleBio, a data-driven techbio company harnessing advances in...